Loading viewer...
investor_presentation
Format: PDF investor_presentation
CloopenGroupHoldingLimited(NYSE:RAAS) 2021Q1 InvestorPresentationJune 10,2021
CloopenGroupHoldingLimited(NYSE:RAAS)
2021Q1 InvestorPresentationJune 10,2021DisclaimerThispresentationhasbeenpreparedbyCloopenGroupHoldingLimited(the“Company”)solelyforinformationalpurposesandhasnotbeenindependentlyverified.Norepresentations,warrantiesorundertakings,expressorimplied,aremadebytheCompanyoranyofitsaffiliatesoradvisersasto,andnorelianceshouldbeplacedupon,theaccuracy,fairness,completenessorcorrectnessoftheinformationoropinionspresentedorcontainedinthispresentation.NoneoftheCompanynoranyofitsaffiliatesoradvisersacceptanyresponsibilitywhatsoever(innegligenceorotherwise)foranylosshowsoeverarisingfromanyinformationpresentedorcontainedinthispresentationorotherwisearisinginconnectionwiththepresentation.Theinformationpresentedorcontainedinthispresentationissubjecttochangewithoutnoticeanditsaccuracyisnotguaranteed.Certainstatementsinthispresentation,andotherstatementsthattheCompanymaymake,areforward-lookingstatements.ThesestatementsreflecttheCompany’sintent,beliefsorcurrentexpectationsaboutthefuture.Thesestatementscanberecognizedbytheuseofwordssuchas“expects,”“plans,”“will,”“estimates,”“projects,”“intends,”“anticipates,”“believes,”“confident”orwordsofsimilarmeaning.Theseforward-lookingstatementsarenotguaranteesoffutureperformanceandarebasedonanumberofassumptionsabouttheCompany’soperationsandotherfactors,manyofwhicharebeyondtheCompany’scontrol,andaccordingly,actualresultsmaydiffermateriallyfromtheseforward-lookingstatements.NeithertheCompanynoranyofitsaffiliatesoradvisershaveanyobligationandtheydonotundertaketoreviseforward-lookingstatementstoreflectfutureeventsorcircumstances.ThispresentationdoesnotconstituteanoffertosellorissueoraninvitationtopurchaseorsubscribeforanysecuritiesoftheCompanyforsaleintheUnitedStatesoranywhereelse.NosecuritiesoftheCompanymaybesoldintheUnitedStateswithoutregistrationwiththeUnitedStatesSecuritiesandExchangeCommission(the“SEC”)oranexemptionfromsuchregistrationpursuanttotheSecuritiesActof1933,asamended(the“SecuritiesAct”)andtherulesandregulationsthereunder.Nopartofthispresentationshallformthebasisoforberelieduponinconnectionwithanycontractorcommitmentwhatsoever.Specifically,thesematerialsdonotconstitutea“prospectus”withinthemeaningoftheSecuritiesAct.ThispresentationdoesnotcontainallrelevantinformationrelatingtotheCompanyoritssecurities,particularlywithrespecttotherisksandspecialconsiderationsinvolvedwithaninvestmentinthesecuritiesoftheCompanyandisqualifiedinitsentiretybyreferencetothedetailedinformationintheprospectusandotherfilingswiththeSEC.Inevaluatingitsbusiness,theCompanyusescertainnon-GAAPmeasuresassupplementalmeasurestoreviewandassessitsoperatingandfinancialperformance.Thesenon-GAAPfinancialmeasureshavelimitationsasanalyticaltools,andwhenassessingtheCompany’soperatingandfinancialperformances,investorsshouldnotconsidertheminisolation,orasasubstituteforanyconsolidatedstatementofoperationsdatapreparedinaccordancewithU.S.GAAP.
1Starting 2021 with Great Momentum
Preview truncated — download the full document for the complete content.
investor_presentation
12 Pages
investor_presentation
29 Pages
Curtiss-Wright Corporation
Teva Pharmaceutical Industries Investor Presentation — February 2017
investor_presentationinvestor_presentation
41 Pages
Teva Pharmaceutical Industries